´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ (¿Â¶óÀÎ)2021³â Ãá°è½ÉÆ÷Áö¾ö : 2021-04-01 |
|
´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ (¿Â¶óÀÎ)2021³â Ãá°è½ÉÆ÷Áö¾ö : 2021-04-01 ±³À°ÀÏÀÚ : 2021-04-01 ±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À° (½Ç½Ã°£ È»ó °ÀÇ) ±³À°ÁÖÁ¦ : (¿Â¶óÀÎ)2021³â Ãá°è½ÉÆ÷Áö¾ö ÁÖÃÖ±â°ü : ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ ´ã´çÀÚ : ±èÈñ¼ø ¿¬¶ôó : 02-795-9914 À̸ÞÀÏ : kscp3@kams.or.kr ±³À°Á¾·ù : Áø´Ü°Ë»çÀÇÇаú Âü¼®¿¹»óÀοø : 500¸í Èñ¸ÁÆòÁ¡ : 6Á¡ Áö¿ª : ¼¿ïƯº°½Ã ±³À°½Ã°£ : 18 ½Ã°£ 30ºÐ ¼¼ºÎ¼ö°·á : 250,000¿ø ºñ°í Á¤È¸¿ø-10¸¸¿ø/ÁØȸ¿ø-8¸¸¿ø/ºñȸ¿ø-25¸¸¿ø ±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 1 (½Ç½Ã°£ ¼ÛÃâ) 09:00~09:30 (Symposium 1) COVID-19¿Í Ç÷¾×ÇÐÀû ÀÌ»ó ±èº¸Çö(¼øõÇâÀÇ´ë) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 1 (½Ç½Ã°£ ¼ÛÃâ) 09:30~10:00 (Symposium 1) Biomarker obtained from automated hematology analyzer for the detection of sepsis ¹Ú»óÇõ(¿ï»êÀÇ´ë) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 1 (½Ç½Ã°£ ¼ÛÃâ) 10:00~10:30 (Symposium 1) ¿ì¸®³ª¶óÀÇ Ç÷¾×¸Å°³º´¿øü °¨¿°ÀÇ Ç÷¾× ¹× °ñ¼ö ¼Ò°ß ±èÇö¿µ(¼º±Õ°üÀÇ´ë) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 2 (½Ç½Ã°£ ¼ÛÃâ) 09:00~09:20 (Workshop 1) ½ÅÀÔ Àü°øÀÇ ¿À¸®¿£Å×ÀÌ¼Ç ±è°æÈñ(°¡ÃµÀÇ´ë) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 2 (½Ç½Ã°£ ¼ÛÃâ) 09:20~09:40 (Workshop 1) ÁöÁú°Ë»çÀÇ Ç¥ÁØÈ ÀÌ»ó±¹(¿¬¼¼ÀÇ´ë) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 2 (½Ç½Ã°£ ¼ÛÃâ) 09:40~10:00 (Workshop 1) ¼öÇ÷ Àü °Ë»çÀÇ Á¤µµ°ü¸® À̹οµ(°µ¿°æÈñ´ëº´¿ø) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 2 (½Ç½Ã°£ ¼ÛÃâ) 10:00~10:30 (Workshop 1) The basics of clinical-grade next-generation sequencing ±èÁöÀº(¼øõÇâÀÇ´ë) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 3 (½Ç½Ã°£ ¼ÛÃâ) 09:00~09:20 (Workshop 2) °Ë»ç½Ç À§Çè°ü¸® Á¶¼º¶õ(¾ÆÁÖÀÇ´ë) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 3 (½Ç½Ã°£ ¼ÛÃâ) 09:20~09:40 (Workshop 2) ½Ã¾à°ü¸®¿Í ¼º´Éºñ±³Æò°¡ ÀÓȯ¼·(Àç)¼¿ïÀÇ°úÇבּ¸¼Ò) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 3 (½Ç½Ã°£ ¼ÛÃâ) 09:40~10:00 (Workshop 2) °Ëü °ü¸® ³ë°æÈ£(±¹¹Î°Ç°º¸Çè Àϻ꺴¿ø) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 3 (½Ç½Ã°£ ¼ÛÃâ) 10:00~10:30 (Workshop 2) ¿ÜºÎÁ¤µµ°ü¸® ´ëüÇÁ·Î±×·¥ ÃÖÁö¼±(°¡Å縯°üµ¿ÀÇ´ë) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 1 (½Ç½Ã°£ ¼ÛÃâ) 10:40~11:40 (Plenary Session 1) Precision medicine in hematology ±èÇüÁØ(Àü³²ÀÇ´ë) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 1 (½Ç½Ã°£ ¼ÛÃâ) 13:00~13:30 (Symposium 2) °áÇÙ Ä¡·áÈ¿°ú Æò°¡¸¦ À§ÇÑ ¹ÙÀÌ¿À¸¶Ä¿ ¿¬±¸ À̼º°æ(Áúº´°ü¸®Ã» ±¹¸³º¸°Ç¿¬±¸¿ø) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 1 (½Ç½Ã°£ ¼ÛÃâ) 13:30~14:00 (Symposium 2) When TCR repertoire analysis meets tuberculosis Á¶À±Á¤(°í·ÁÀÇ´ë) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 1 (½Ç½Ã°£ ¼ÛÃâ) 14:00~14:30 (Symposium 2) Metabolomics to elucidate the mechanisms in multi-drug resistant tuberculosis Ȳ¿µÀÚ(°í·Á´ëÇб³ ¾àÇдëÇÐ) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 2 (½Ç½Ã°£ ¼ÛÃâ) 13:00~13:25 (Symposium 3) ³í¹® ÀÛ¼º°ú ½É»ç °æÇè Çã¹Ì³ª(°Ç±¹ÀÇ´ë) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 2 (½Ç½Ã°£ ¼ÛÃâ) 13:25~13:50 (Symposium 3) Áø´Ü°Ë»çÀÇÇÐ ³í¹®ÀÛ¼º½Ã °í·ÁÇØ¾ß ÇÒ Åë°èºÐ¼® À̽ÂÈ£(¾ÆÁÖ´ëÇб³ÀÇ·á¿ø Á÷¾÷ȯ°æÀÇÇб³½Ç) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 2 (½Ç½Ã°£ ¼ÛÃâ) 13:50~14:10 (Symposium 3) ¿¬±¸À±¸® - Ç¥Àý ¹æÇØÀÎ(¼øõÇâÀÇ´ë) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 2 (½Ç½Ã°£ ¼ÛÃâ) 14:10~14:30 (Symposium 3) Ann Lab MedÀÇ ¹ßÀü°ú º¯È ±è¿µÁø(°æÈñÀÇ´ë) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 3 (½Ç½Ã°£ ¼ÛÃâ) 13:00~13:30 (Workshop 3) ÁöµµÀü¹®ÀÇ ÀÚ°Ý ¹× ¿ªÇÒ ¹Ú¿ëÁ¤(¿¬¼¼ÀÇ´ë) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 3 (½Ç½Ã°£ ¼ÛÃâ) 13:30~14:00 (Workshop 3) Àü¹®ÀÇ ½ÃÇè¹®Ç× ÃâÁ¦ °¡À̵å¶óÀÎ È«À±Áö(¼¿ïÀÇ´ë) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 3 (½Ç½Ã°£ ¼ÛÃâ) 14:00~14:30 (Workshop 3) °Ë»ç½Ç ¾ÈÀü°ú Äڷγª19 °¨¿°°ü¸® ¹ÚÁ¤¼ö(¼¿ïÀÇ´ë) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 3 (½Ç½Ã°£ ¼ÛÃâ) 14:30~15:00 (Workshop 3) Äڷγª19 Ç×ü°Ë»çÀÇ ÀÇ¹Ì¿Í È°¿ë ¿ÀÀºÁö(°¡Å縯ÀÇ´ë) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 3 (½Ç½Ã°£ ¼ÛÃâ) 15:00~15:30 (Workshop 3) Áø´Ü°Ë»çÀÇÇÐ ¿ë¾î ¹Ù·Î ¾Ë±â, Áø´Ü°Ë»çÀÇÇÐ °³Á¤¿ë¾îÁý ±â¹Ý ÇöÁ¤¿ø(ÇѸ²ÀÇ´ë) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 3 (½Ç½Ã°£ ¼ÛÃâ) 15:30~16:00 (Workshop 3) Áø´Ü°Ë»çÀÇÇÐ ÇÚµåºÏ, 100% È°¿ëÇϱâ ÀÓÁø¼÷(Ãæ³²ÀÇ´ë) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 3 (½Ç½Ã°£ ¼ÛÃâ) 16:00~16:30 (Workshop 3) Áø´Ü°Ë»çÀÇÇÐ ÀÇ»ç·Î¼ ¾Ë¾ÆµÎ¸é ÁÁÀ» µö·¯´× Åø ¼Ò°³ ÃÖ±ÔÅÂ(Ãæ³²ÀÇ´ë) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 3 (½Ç½Ã°£ ¼ÛÃâ) 16:30~17:00 (Workshop 3) ü¿ÜÁø´ÜÀÇ·á±â±â¹ý°ú ÀÓ»óÀû¼º´É½ÃÇè(±â°ü) ±âÁØ °¡À̵å¶óÀÎ Á¶¼ºÁø(°¡Å縯ÀÇ´ë) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 1 (½Ç½Ã°£ ¼ÛÃâ) 14:40~15:10 (Symposium 4) ½ÅÁ¾Äڷγª¹ÙÀÌ·¯½ºÀÇ À¯ÀüÀÚ ±¸Á¶¿Í º¯ÀÌ ¿ÀÁö¿ø(°æºÏÀÇ´ë ÇغÎÇб³½Ç) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 1 (½Ç½Ã°£ ¼ÛÃâ) 15:10~15:40 (Symposium 4) COVID-19ÀÇ ºÐÀÚÁø´Ü±â¹ý ±è¼Ò¿¬(±¹¸³Áß¾ÓÀÇ·á¿ø) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 1 (½Ç½Ã°£ ¼ÛÃâ) 15:40~16:10 (Symposium 4) »õ·Î¿î COVID-19 Áø´Ü±â¹ý È«±âÈ£(¿¬¼¼ÀÇ´ë) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 2 (½Ç½Ã°£ ¼ÛÃâ) 14:40~15:00 (Symposium 5) Ç°Áú°ü¸®Ã¼°è ±è¼ÖÀÙ(ÀÎÁ¦ÀÇ´ë) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 2 (½Ç½Ã°£ ¼ÛÃâ) 15:00~15:20 (Symposium 5) °úÁ¤°ü¸® ¼µ¿Èñ(·¦Áö³ë¹Í½º) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 2 (½Ç½Ã°£ ¼ÛÃâ) 15:20~15:40 (Symposium 5) »ç°Ç°ü¸® ÀÌ¿µ°æ(ÇѸ²ÀÇ´ë) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 2 (½Ç½Ã°£ ¼ÛÃâ) 15:40~16:10 (Symposium 5) Á¤º¸°ü¸® À±¿µ¾È(¼øõÇâÀÇ´ë) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 1 (½Ç½Ã°£ ¼ÛÃâ) 16:20~16:35 (Symposium 6) C49, ü¾× ÈÇÐ °Ë»ç ÀÓÁ¤ÈÆ(¿¬¼¼ÀÇ´ë) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 1 (½Ç½Ã°£ ¼ÛÃâ) 16:35~16:50 (Symposium 6) EP09, ȯÀÚ °Ëü¸¦ ÀÌ¿ëÇÑ ÃøÁ¤ÀýÂ÷ ºñ±³ ¹× ¹ÙÀ̾ ÃßÁ¤ À¯ÀºÇü(´ë±¸°¡Å縯ÀÇ´ë) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 1 (½Ç½Ã°£ ¼ÛÃâ) 16:50~17:05 (Symposium 6) EP34, °Ëü Èñ¼®°ú ÷°¡¸¦ ÅëÇÑ È®ÀåÃøÁ¤±¸°£ ¼³Á¤ ¹× °ËÁ¤ Á¤ÈñÁ¤(°Ç±¹ÀÇ´ë) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 1 (½Ç½Ã°£ ¼ÛÃâ) 17:05~17:20 (Symposium 6) GP40, ÀÓ»ó°Ë»ç½Ç¿¡¼ ½Ã¾à ¼öÀÇ Áغñ¿Í °Ë»ç Á¶ÀºÁ¤(ÇѸ²ÀÇ´ë) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 1 (½Ç½Ã°£ ¼ÛÃâ) 17:20~17:50 (Symposium 6) MM17, ´ÙÁßÇÙ»ê°Ë»çÀÇ °ËÁõ ¹× °ËÁ¤ ±è¿µ¾Æ(±¹¹Î°Ç°º¸Çè Àϻ꺴¿ø) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 2 (½Ç½Ã°£ ¼ÛÃâ) 16:20~16:50 (Symposium 7) Ä¡·áÇϱ⠾î·Á¿î °¨¿°¿¡ ´ëÇÑ ¸ð´ÏÅ͸µ ÀÌÇõ¹Î(¿¬¼¼ÀÇ´ë) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 2 (½Ç½Ã°£ ¼ÛÃâ) 16:50~17:20 (Symposium 7) Ä¡·áÇϱ⠾î·Á¿î °¨¿°¿¡ ´ëÇÑ ´ëÀÀ: Áø´Ü°Ë»çÀÇÇÐ ºÐ¾ß ¹Ú°æ¿î(¼¿ïÀÇ´ë) ±³À°½Ã°£ 04¿ù 01ÀÏ Channel 2 (½Ç½Ã°£ ¼ÛÃâ) 17:20~17:50 (Symposium 7) The pivotal role of DIAGNOSTICS and our joint responsibility in battling the global threat of AMR Mark Miller(BioMérieux Inc. Canada) |
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù. |
|